Category: DAIC Articles

FDA Approves COBRA REDUCE Trial Expansion

October 27, 2017

“CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of CeloNova’s ongoing clinical trial of its proprietary Cobra PzF NanoCoated Coronary Stent (NCS) with 14-day dual antiplatelet therapy (DAPT) in complex patients, such as those who are at high bleeding risk.”

Visit Website

VIDEO: Transcaval Access in TAVR Procedures

October 27, 2017

“Adam Greenbaum, M.D., co-director of the structural heart program at Henry Ford Health System in Detroit, discusses the innovative approach to transcatheter aortic valve replacement (TAVR) being pioneered at HFHS.”

Visit Website

Detroit Cardiogenic Shock Initiative Goes National at TCT 2017

October 26, 2017

“Medical professionals representing hospital systems from across the United States are expected to attend the first National Cardiogenic Shock Initiative (NCSI) meeting Oct. 29 in Denver. The gathering will help kick off Transcatheter Cardiovascular Therapeutics (TCT) 2017, an annual educational meeting specializing in interventional cardiovascular medicine.”

Visit Website
Page 30 of 44«...510152025...2829303132...3540...»